Women Health Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type (Devices, Drugs, Pharmaceutical Pipeline); Treatment Type (Hormonal Treatment, Non-Hormonal Treatment, Surgeries); Diagnosis (Bone Densitometry, Diagnostic Imaging Tests, Biopsies, Ovulation Testing, Others); Disease Indication (Cancer, Reproductive Health, Post-Menopausal Syndrome, Urological Disorders); End-Users (Hospital and clinics, Gynecology centers, Research Institutes, Others) and Geography

Report Code: TIPRE00018288 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming
Covid
MARKET INTRODUCTION

Women's health includes all of the drugs, therapeutics, precautionary measures, surgical offerings for the various disease and disorders associated with the women population. These disorders vary from oncology, nutrition, reproductive health, menstrual, urological as well as other healthcare applications. Women's health emphasizes on providing better management of diseases and improving the overall health of females. The science which specifically deals with women health is known as gynecology.

MARKET DYNAMICS

The key market drivers for Women Health Market Includes, Increasing awareness about women health along with various R&D activities by research companies for proving better therapeutics and health care to women. Moreover, changes in lifestyle which leads to bad nutrition intake is also expected to fuel market growth during forecast period. Additionally, various initiatives taken by governments to promote women health is also expected to boost market growth during forecast period. Whereas, patent expiration of branded drugs along with potential side effects from drug treatment is expected to hamper market growth during forecast period.

MARKET SCOPE

The "Women Health Market" is a specialized and in-depth study of the Healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Women Health market with detailed market segmentation by Product type, treatment type, diagnosis, disease indication and end user. The Women Health Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Women Health Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Women Health Market is segmented on the basis of Product type, treatment type, diagnosis, disease indication and end user. On the basis of product type the market is segmented as, devices, drugs, pharmaceutical pipeline. On the basis of treatment type the market is segmented as, hormonal treatment, non-hormonal treatment, surgery. On the basis of diagnosis the market is segmented as, diagnostic imaging test, biopsis, ovulation testing, others. On the basis of disease indication the market is segmented as, cancer, reproductive health, post- menopausal syndrome, urological disorders. And on the basis of end user the market is segmented as, hospitals, clinics, gynecology centers, research institutes, others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Women Health Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Women Health Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Women Health Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Women Health Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Women Health Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Women Health Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Women Health market in the global market. Below mentioned is the list of few companies engaged in the Women Health Market.

The report also includes the profiles of key players in Women Health Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Eli Lilly and Company
  •   Novartis AG
  •   Pfizer, Inc.
  •   Merck and Co., Inc.
  •   Novo Nordisk A/S
  •   Amgen, Inc.
  •   Lupin Pharmaceuticals, Inc.
  •   AstraZeneca
  •   Sanofi
  •   F. Hoffmann-La Roche Ltd

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Women Health Market - By Product Type
1.3.2 Women Health Market - By Treatment Type
1.3.3 Women Health Market - By Diagnosis
1.3.4 Women Health Market - By Disease Indication
1.3.5 Women Health Market - By End-Users
1.3.6 Women Health Market - By Region
1.3.6.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. WOMEN HEALTH MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. WOMEN HEALTH MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. WOMEN HEALTH MARKET - GLOBAL MARKET ANALYSIS
6.1. WOMEN HEALTH - GLOBAL MARKET OVERVIEW
6.2. WOMEN HEALTH - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. WOMEN HEALTH MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. DEVICES
7.3.1. Overview
7.3.2. Devices Market Forecast and Analysis
7.3.3. Intra Uterine Devices Market
7.3.3.1. Overview
7.3.3.2. Intra Uterine Devices Market Forecast and Analysis
7.3.4. Vaginal Rings Market
7.3.4.1. Overview
7.3.4.2. Vaginal Rings Market Forecast and Analysis
7.3.5. Implants Market
7.3.5.1. Overview
7.3.5.2. Implants Market Forecast and Analysis
7.3.6. Female Condoms Market
7.3.6.1. Overview
7.3.6.2. Female Condoms Market Forecast and Analysis
7.4. DRUGS
7.4.1. Overview
7.4.2. Drugs Market Forecast and Analysis
7.4.3. Menopause Drugs Market
7.4.3.1. Overview
7.4.3.2. Menopause Drugs Market Forecast and Analysis
7.4.4. Menopausal Hot Flashes Drugs Market
7.4.4.1. Overview
7.4.4.2. Menopausal Hot Flashes Drugs Market Forecast and Analysis
7.5. PHARMACEUTICAL PIPELINE
7.5.1. Overview
7.5.2. Pharmaceutical Pipeline Market Forecast and Analysis
8. WOMEN HEALTH MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT TYPE
8.1. OVERVIEW
8.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
8.3. HORMONAL TREATMENT
8.3.1. Overview
8.3.2. Hormonal Treatment Market Forecast and Analysis
8.3.3. Estrogen Therapy Market
8.3.3.1. Overview
8.3.3.2. Estrogen Therapy Market Forecast and Analysis
8.3.4. Progestin Therapy Market
8.3.4.1. Overview
8.3.4.2. Progestin Therapy Market Forecast and Analysis
8.3.5. Combination Therapy Market
8.3.5.1. Overview
8.3.5.2. Combination Therapy Market Forecast and Analysis
8.3.6. Thyroid Replacement Therapy Market
8.3.6.1. Overview
8.3.6.2. Thyroid Replacement Therapy Market Forecast and Analysis
8.3.7. Parathyroid Hormone Therapy Market
8.3.7.1. Overview
8.3.7.2. Parathyroid Hormone Therapy Market Forecast and Analysis
8.4. NON-HORMONAL TREATMENT
8.4.1. Overview
8.4.2. Non-Hormonal Treatment Market Forecast and Analysis
8.4.3. Targeted Therapy Market
8.4.3.1. Overview
8.4.3.2. Targeted Therapy Market Forecast and Analysis
8.4.4. Drugs Market
8.4.4.1. Overview
8.4.4.2. Drugs Market Forecast and Analysis
8.4.5. Antibiotics Market
8.4.5.1. Overview
8.4.5.2. Antibiotics Market Forecast and Analysis
8.4.6. Bisphosphonates Market
8.4.6.1. Overview
8.4.6.2. Bisphosphonates Market Forecast and Analysis
8.4.7. Others Market
8.4.7.1. Overview
8.4.7.2. Others Market Forecast and Analysis
8.5. SURGERIES
8.5.1. Overview
8.5.2. Surgeries Market Forecast and Analysis
9. WOMEN HEALTH MARKET - REVENUE AND FORECASTS TO 2027 - DIAGNOSIS
9.1. OVERVIEW
9.2. DIAGNOSIS MARKET FORECASTS AND ANALYSIS
9.3. BONE DENSITOMETRY
9.3.1. Overview
9.3.2. Bone Densitometry Market Forecast and Analysis
9.4. DIAGNOSTIC IMAGING TESTS
9.4.1. Overview
9.4.2. Diagnostic Imaging Tests Market Forecast and Analysis
9.5. BIOPSIES
9.5.1. Overview
9.5.2. Biopsies Market Forecast and Analysis
9.6. OVULATION TESTING
9.6.1. Overview
9.6.2. Ovulation Testing Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. WOMEN HEALTH MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE INDICATION
10.1. OVERVIEW
10.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
10.3. CANCER
10.3.1. Overview
10.3.2. Cancer Market Forecast and Analysis
10.3.3. Breast Cancer Market
10.3.3.1. Overview
10.3.3.2. Breast Cancer Market Forecast and Analysis
10.3.4. Cervical Cancer Market
10.3.4.1. Overview
10.3.4.2. Cervical Cancer Market Forecast and Analysis
10.3.5. Ovarian Cancer Market
10.3.5.1. Overview
10.3.5.2. Ovarian Cancer Market Forecast and Analysis
10.4. REPRODUCTIVE HEALTH
10.4.1. Overview
10.4.2. Reproductive Health Market Forecast and Analysis
10.4.3. Infertility Market
10.4.3.1. Overview
10.4.3.2. Infertility Market Forecast and Analysis
10.4.4. Endometriosis Market
10.4.4.1. Overview
10.4.4.2. Endometriosis Market Forecast and Analysis
10.4.5. PCOS Market
10.4.5.1. Overview
10.4.5.2. PCOS Market Forecast and Analysis
10.5. POST-MENOPAUSAL SYNDROME
10.5.1. Overview
10.5.2. Post-Menopausal Syndrome Market Forecast and Analysis
10.5.3. Osteoporosis Market
10.5.3.1. Overview
10.5.3.2. Osteoporosis Market Forecast and Analysis
10.5.4. Menopause Market
10.5.4.1. Overview
10.5.4.2. Menopause Market Forecast and Analysis
10.6. UROLOGICAL DISORDERS
10.6.1. Overview
10.6.2. Urological Disorders Market Forecast and Analysis
10.6.3. Urinary Incontinence Market
10.6.3.1. Overview
10.6.3.2. Urinary Incontinence Market Forecast and Analysis
10.6.4. Uterine Fibroid Market
10.6.4.1. Overview
10.6.4.2. Uterine Fibroid Market Forecast and Analysis
10.6.5. Urinary Tract Infections (UTIs) Market
10.6.5.1. Overview
10.6.5.2. Urinary Tract Infections (UTIs) Market Forecast and Analysis
11. WOMEN HEALTH MARKET - REVENUE AND FORECASTS TO 2027 - END-USERS
11.1. OVERVIEW
11.2. END-USERS MARKET FORECASTS AND ANALYSIS
11.3. HOSPITAL AND CLINICS
11.3.1. Overview
11.3.2. Hospital and clinics Market Forecast and Analysis
11.4. GYNECOLOGY CENTERS
11.4.1. Overview
11.4.2. Gynecology centers Market Forecast and Analysis
11.5. RESEARCH INSTITUTES
11.5.1. Overview
11.5.2. Research Institutes Market Forecast and Analysis
11.6. OTHERS
11.6.1. Overview
11.6.2. Others Market Forecast and Analysis

12. WOMEN HEALTH MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Women Health Market Overview
12.1.2 North America Women Health Market Forecasts and Analysis
12.1.3 North America Women Health Market Forecasts and Analysis - By Product Type
12.1.4 North America Women Health Market Forecasts and Analysis - By Treatment Type
12.1.5 North America Women Health Market Forecasts and Analysis - By Diagnosis
12.1.6 North America Women Health Market Forecasts and Analysis - By Disease Indication
12.1.7 North America Women Health Market Forecasts and Analysis - By End-Users
12.1.8 North America Women Health Market Forecasts and Analysis - By Countries
12.1.8.1 United States Women Health Market
12.1.8.1.1 United States Women Health Market by Product Type
12.1.8.1.2 United States Women Health Market by Treatment Type
12.1.8.1.3 United States Women Health Market by Diagnosis
12.1.8.1.4 United States Women Health Market by Disease Indication
12.1.8.1.5 United States Women Health Market by End-Users
12.1.8.2 Canada Women Health Market
12.1.8.2.1 Canada Women Health Market by Product Type
12.1.8.2.2 Canada Women Health Market by Treatment Type
12.1.8.2.3 Canada Women Health Market by Diagnosis
12.1.8.2.4 Canada Women Health Market by Disease Indication
12.1.8.2.5 Canada Women Health Market by End-Users
12.1.8.3 Mexico Women Health Market
12.1.8.3.1 Mexico Women Health Market by Product Type
12.1.8.3.2 Mexico Women Health Market by Treatment Type
12.1.8.3.3 Mexico Women Health Market by Diagnosis
12.1.8.3.4 Mexico Women Health Market by Disease Indication
12.1.8.3.5 Mexico Women Health Market by End-Users
12.2. EUROPE
12.2.1 Europe Women Health Market Overview
12.2.2 Europe Women Health Market Forecasts and Analysis
12.2.3 Europe Women Health Market Forecasts and Analysis - By Product Type
12.2.4 Europe Women Health Market Forecasts and Analysis - By Treatment Type
12.2.5 Europe Women Health Market Forecasts and Analysis - By Diagnosis
12.2.6 Europe Women Health Market Forecasts and Analysis - By Disease Indication
12.2.7 Europe Women Health Market Forecasts and Analysis - By End-Users
12.2.8 Europe Women Health Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Women Health Market
12.2.8.1.1 Germany Women Health Market by Product Type
12.2.8.1.2 Germany Women Health Market by Treatment Type
12.2.8.1.3 Germany Women Health Market by Diagnosis
12.2.8.1.4 Germany Women Health Market by Disease Indication
12.2.8.1.5 Germany Women Health Market by End-Users
12.2.8.2 France Women Health Market
12.2.8.2.1 France Women Health Market by Product Type
12.2.8.2.2 France Women Health Market by Treatment Type
12.2.8.2.3 France Women Health Market by Diagnosis
12.2.8.2.4 France Women Health Market by Disease Indication
12.2.8.2.5 France Women Health Market by End-Users
12.2.8.3 Italy Women Health Market
12.2.8.3.1 Italy Women Health Market by Product Type
12.2.8.3.2 Italy Women Health Market by Treatment Type
12.2.8.3.3 Italy Women Health Market by Diagnosis
12.2.8.3.4 Italy Women Health Market by Disease Indication
12.2.8.3.5 Italy Women Health Market by End-Users
12.2.8.4 Spain Women Health Market
12.2.8.4.1 Spain Women Health Market by Product Type
12.2.8.4.2 Spain Women Health Market by Treatment Type
12.2.8.4.3 Spain Women Health Market by Diagnosis
12.2.8.4.4 Spain Women Health Market by Disease Indication
12.2.8.4.5 Spain Women Health Market by End-Users
12.2.8.5 United Kingdom Women Health Market
12.2.8.5.1 United Kingdom Women Health Market by Product Type
12.2.8.5.2 United Kingdom Women Health Market by Treatment Type
12.2.8.5.3 United Kingdom Women Health Market by Diagnosis
12.2.8.5.4 United Kingdom Women Health Market by Disease Indication
12.2.8.5.5 United Kingdom Women Health Market by End-Users
12.2.8.6 Rest of Europe Women Health Market
12.2.8.6.1 Rest of Europe Women Health Market by Product Type
12.2.8.6.2 Rest of Europe Women Health Market by Treatment Type
12.2.8.6.3 Rest of Europe Women Health Market by Diagnosis
12.2.8.6.4 Rest of Europe Women Health Market by Disease Indication
12.2.8.6.5 Rest of Europe Women Health Market by End-Users
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Women Health Market Overview
12.3.2 Asia-Pacific Women Health Market Forecasts and Analysis
12.3.3 Asia-Pacific Women Health Market Forecasts and Analysis - By Product Type
12.3.4 Asia-Pacific Women Health Market Forecasts and Analysis - By Treatment Type
12.3.5 Asia-Pacific Women Health Market Forecasts and Analysis - By Diagnosis
12.3.6 Asia-Pacific Women Health Market Forecasts and Analysis - By Disease Indication
12.3.7 Asia-Pacific Women Health Market Forecasts and Analysis - By End-Users
12.3.8 Asia-Pacific Women Health Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Women Health Market
12.3.8.1.1 Australia Women Health Market by Product Type
12.3.8.1.2 Australia Women Health Market by Treatment Type
12.3.8.1.3 Australia Women Health Market by Diagnosis
12.3.8.1.4 Australia Women Health Market by Disease Indication
12.3.8.1.5 Australia Women Health Market by End-Users
12.3.8.2 China Women Health Market
12.3.8.2.1 China Women Health Market by Product Type
12.3.8.2.2 China Women Health Market by Treatment Type
12.3.8.2.3 China Women Health Market by Diagnosis
12.3.8.2.4 China Women Health Market by Disease Indication
12.3.8.2.5 China Women Health Market by End-Users
12.3.8.3 India Women Health Market
12.3.8.3.1 India Women Health Market by Product Type
12.3.8.3.2 India Women Health Market by Treatment Type
12.3.8.3.3 India Women Health Market by Diagnosis
12.3.8.3.4 India Women Health Market by Disease Indication
12.3.8.3.5 India Women Health Market by End-Users
12.3.8.4 Japan Women Health Market
12.3.8.4.1 Japan Women Health Market by Product Type
12.3.8.4.2 Japan Women Health Market by Treatment Type
12.3.8.4.3 Japan Women Health Market by Diagnosis
12.3.8.4.4 Japan Women Health Market by Disease Indication
12.3.8.4.5 Japan Women Health Market by End-Users
12.3.8.5 South Korea Women Health Market
12.3.8.5.1 South Korea Women Health Market by Product Type
12.3.8.5.2 South Korea Women Health Market by Treatment Type
12.3.8.5.3 South Korea Women Health Market by Diagnosis
12.3.8.5.4 South Korea Women Health Market by Disease Indication
12.3.8.5.5 South Korea Women Health Market by End-Users
12.3.8.6 Rest of Asia-Pacific Women Health Market
12.3.8.6.1 Rest of Asia-Pacific Women Health Market by Product Type
12.3.8.6.2 Rest of Asia-Pacific Women Health Market by Treatment Type
12.3.8.6.3 Rest of Asia-Pacific Women Health Market by Diagnosis
12.3.8.6.4 Rest of Asia-Pacific Women Health Market by Disease Indication
12.3.8.6.5 Rest of Asia-Pacific Women Health Market by End-Users
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Women Health Market Overview
12.4.2 Middle East and Africa Women Health Market Forecasts and Analysis
12.4.3 Middle East and Africa Women Health Market Forecasts and Analysis - By Product Type
12.4.4 Middle East and Africa Women Health Market Forecasts and Analysis - By Treatment Type
12.4.5 Middle East and Africa Women Health Market Forecasts and Analysis - By Diagnosis
12.4.6 Middle East and Africa Women Health Market Forecasts and Analysis - By Disease Indication
12.4.7 Middle East and Africa Women Health Market Forecasts and Analysis - By End-Users
12.4.8 Middle East and Africa Women Health Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Women Health Market
12.4.8.1.1 South Africa Women Health Market by Product Type
12.4.8.1.2 South Africa Women Health Market by Treatment Type
12.4.8.1.3 South Africa Women Health Market by Diagnosis
12.4.8.1.4 South Africa Women Health Market by Disease Indication
12.4.8.1.5 South Africa Women Health Market by End-Users
12.4.8.2 Saudi Arabia Women Health Market
12.4.8.2.1 Saudi Arabia Women Health Market by Product Type
12.4.8.2.2 Saudi Arabia Women Health Market by Treatment Type
12.4.8.2.3 Saudi Arabia Women Health Market by Diagnosis
12.4.8.2.4 Saudi Arabia Women Health Market by Disease Indication
12.4.8.2.5 Saudi Arabia Women Health Market by End-Users
12.4.8.3 U.A.E Women Health Market
12.4.8.3.1 U.A.E Women Health Market by Product Type
12.4.8.3.2 U.A.E Women Health Market by Treatment Type
12.4.8.3.3 U.A.E Women Health Market by Diagnosis
12.4.8.3.4 U.A.E Women Health Market by Disease Indication
12.4.8.3.5 U.A.E Women Health Market by End-Users
12.4.8.4 Rest of Middle East and Africa Women Health Market
12.4.8.4.1 Rest of Middle East and Africa Women Health Market by Product Type
12.4.8.4.2 Rest of Middle East and Africa Women Health Market by Treatment Type
12.4.8.4.3 Rest of Middle East and Africa Women Health Market by Diagnosis
12.4.8.4.4 Rest of Middle East and Africa Women Health Market by Disease Indication
12.4.8.4.5 Rest of Middle East and Africa Women Health Market by End-Users
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Women Health Market Overview
12.5.2 South and Central America Women Health Market Forecasts and Analysis
12.5.3 South and Central America Women Health Market Forecasts and Analysis - By Product Type
12.5.4 South and Central America Women Health Market Forecasts and Analysis - By Treatment Type
12.5.5 South and Central America Women Health Market Forecasts and Analysis - By Diagnosis
12.5.6 South and Central America Women Health Market Forecasts and Analysis - By Disease Indication
12.5.7 South and Central America Women Health Market Forecasts and Analysis - By End-Users
12.5.8 South and Central America Women Health Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Women Health Market
12.5.8.1.1 Brazil Women Health Market by Product Type
12.5.8.1.2 Brazil Women Health Market by Treatment Type
12.5.8.1.3 Brazil Women Health Market by Diagnosis
12.5.8.1.4 Brazil Women Health Market by Disease Indication
12.5.8.1.5 Brazil Women Health Market by End-Users
12.5.8.2 Argentina Women Health Market
12.5.8.2.1 Argentina Women Health Market by Product Type
12.5.8.2.2 Argentina Women Health Market by Treatment Type
12.5.8.2.3 Argentina Women Health Market by Diagnosis
12.5.8.2.4 Argentina Women Health Market by Disease Indication
12.5.8.2.5 Argentina Women Health Market by End-Users
12.5.8.3 Rest of South and Central America Women Health Market
12.5.8.3.1 Rest of South and Central America Women Health Market by Product Type
12.5.8.3.2 Rest of South and Central America Women Health Market by Treatment Type
12.5.8.3.3 Rest of South and Central America Women Health Market by Diagnosis
12.5.8.3.4 Rest of South and Central America Women Health Market by Disease Indication
12.5.8.3.5 Rest of South and Central America Women Health Market by End-Users

13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

14. WOMEN HEALTH MARKET, KEY COMPANY PROFILES
14.1. ELI LILLY AND COMPANY
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. NOVARTIS AG
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. PFIZER INC
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. MERCK AND CO., INC
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. NOVO NORDISK A/S
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. AMGEN INC
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. LUPIN PHARMACEUTICALS, INC
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. ASTRAZENECA
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. F. HOFFMANN-LA ROCHE LTD
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. SANOFI
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments

15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies

1. Eli Lilly and Company
2. Novartis AG
3. Pfizer Inc
4. Merck and Co., Inc
5. Novo Nordisk A/S
6. Amgen Inc
7. Lupin Pharmaceuticals, Inc
8. AstraZeneca
9. F. Hoffmann-La Roche Ltd
10. Sanofi
TIPRE00018288
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking